Honeywell International Impairment of assets held for sale increased by 3.1% to $263.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1653.3%, from $15.00M to $263.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests poor asset valuation or declining market demand for non-core business units, while a decrease indicates stable asset values or successful divestiture execution.
This represents non-cash charges recognized when the carrying value of long-lived assets held for sale exceeds their fai...
Common in large pharmaceutical companies undergoing portfolio restructuring or M&A integration.
operating_impairment_of_long_lived_assets_to_be_disposed_of| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $125.00M | $94.00M | $15.00M | $0.00 | $0.00 | $255.00M | $263.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | -24.8% | -84.0% | -100.0% | — | — | +3.1% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% | +171.3% | >999% |